Insiders · VLON

VLON insider transactions

Vallon Pharmaceuticals Inc. (VLON) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for VLON

• 942d
  SEC Form 4 filed by Kelly Leanne

  4 - GRI BIO, Inc. (0001824293) (Issuer)
• 985d
  SEC Form 4 filed by Szekeres David Leslie

  4 - GRI BIO, Inc. (0001824293) (Issuer)
• 985d
  SEC Form 4 filed by Simpson Camilla V

  4 - GRI BIO, Inc. (0001824293) (Issuer)
• 985d
  SEC Form 4 filed by Rongen Roelof

  4 - GRI BIO, Inc. (0001824293) (Issuer)
• 985d
  SEC Form 4 filed by Baker David Charles

  4 - GRI BIO, Inc. (0001824293) (Issuer)
• 1096d
  SEC Form 3 filed by new insider Chaturvedi Vipin

  3 - GRI BIO, Inc. (0001824293) (Issuer)
• 1096d
  SEC Form 3 filed by new insider Simpson Camilla V

  3 - GRI BIO, Inc. (0001824293) (Issuer)
• 1096d
  SEC Form 3 filed by new insider Agro Albert

  3 - GRI BIO, Inc. (0001824293) (Issuer)
• 1096d
  SEC Form 3 filed by new insider Rongen Roelof

  3 - GRI BIO, Inc. (0001824293) (Issuer)
• 1096d
  SEC Form 3 filed by new insider Hertz Walter Marc

  3 - GRI BIO, Inc. (0001824293) (Issuer)
• 1097d
  SEC Form 4 filed by Hertz Walter Marc

  4 - GRI BIO, Inc. (0001824293) (Issuer)
• 1097d
  SEC Form 4 filed by Agro Albert

  4 - GRI BIO, Inc. (0001824293) (Issuer)
• 1097d
  SEC Form 4 filed by Chaturvedi Vipin

  4 - GRI BIO, Inc. (0001824293) (Issuer)
• 1097d
  SEC Form 3 filed by new insider Szekeres David Leslie

  3 - GRI BIO, Inc. (0001824293) (Issuer)
• 1227d
  SEC Form 4: Thorell Marella disposed of 28,517 shares, decreasing direct ownership by 75% to 9,506 units

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1389d
  SEC Form 4: Thorell Marella was granted 38,023 shares

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1415d
  SEC Form 4 filed by Ammer Richard

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1415d
  SEC Form 4 filed by Payne Joseph E

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1415d
  SEC Form 4 filed by Thorell Marella

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1508d
  SEC Form 4 filed by Chhabra Meenu

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1508d
  SEC Form 3 filed by new insider Chhabra Meenu

  3 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1516d
  SEC Form 4 filed by Baker David Charles

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1516d
  SEC Form 4 filed by Kelly Leanne M.

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1786d
  SEC Form 4: Kelly Leanne M. bought $25,175 worth of Common Stock (6,250 units at $4.03)

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1794d
  SEC Form 4 filed by Vallon Pharmaceuticals Inc.

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1803d
  SEC Form 4 filed by Payne Joseph E

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1803d
  SEC Form 4 filed by Ammer Richard

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1803d
  SEC Form 4 filed by Toren Penny

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)
• 1803d
  SEC Form 4 filed by Baker David Charles

  4 - Vallon Pharmaceuticals, Inc. (0001824293) (Issuer)